Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Echocardiography, perfusion scintigraphy, or both?

Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with... Pharmacological stress echocardiography and myocardial perfusion scintigraphy are used frequently for risk stratification in patients with suspected myocardial ischemia. However, their relative prognostic strength has never been explored. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Circulation Pubmed

Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Echocardiography, perfusion scintigraphy, or both?

Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Echocardiography, perfusion scintigraphy, or both?


Abstract

Pharmacological stress echocardiography and myocardial perfusion scintigraphy are used frequently for risk stratification in patients with suspected myocardial ischemia. However, their relative prognostic strength has never been explored.

Loading next page...
 
/lp/pubmed/cardiac-imaging-for-risk-stratification-with-dobutamine-atropine-sKKhGKq3Fh

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0009-7322
DOI
10.1161/01.cir.96.1.137
pmid
9236428

Abstract

Pharmacological stress echocardiography and myocardial perfusion scintigraphy are used frequently for risk stratification in patients with suspected myocardial ischemia. However, their relative prognostic strength has never been explored.

Journal

CirculationPubmed

Published: Aug 14, 1997

There are no references for this article.